Diagnostics for SARS-CoV-2

Main features:

• CE-IVD
• First intention diagnostic Reverse Transcription qPCR-based (RT-qPCR) tests
• Ready-to-use
• Designed for nucleic acid extracted from naso- and oropharyngeal swab samples, and sputum samples
• Contain endogenous human gene control for confirmation of sample presence
• Quick – duration of the protocol is up to 1 hour
• Compatible with qPCR thermocyclers with three (triplex) or five (pentaplex) channels:
  • FAM, HEX/VIC, Cy5 (for Triplex kits) and additional
  • ROX/CAL Fluor Red 610, Cy5.5 (for Pentaplex kit)

Kits for SARS-CoV-2 variants discrimination:

SARS-CoV-2 / VOC Revolution Pentaplex

• The kit detects:
  • three SARS-CoV-2 targets (one for N protein and two for RdRP) 
  • presence of L452R, E484K and K417N mutations
• Limit of Detection (LOD95%):
  • 10 copies/PCR for SARS-CoV-2 and K417N mutation
  • 40 copies/PCR for L452R and E484K mutations

Available packages:

• IDSARSCOV-REV-100 (100 tests)
• IDSARSCOV-REV-500 (500 tests)

Kits for SARS-CoV-2 presence screening:

SARS-CoV-2 / Influenza Triplex 

• Allows to differentiate seasonal Influenza A/B from SARS-CoV-2 infection
• Dual-detection for SARS-CoV-2: nucleocapsid (N) and RNA polymerase (RdRp)
• Dual-detection for Influenza: matrix (MP) for Influenza A, non structural proteins (NSP) for Influenza B
• Limit of Detection (LOD95%): < 15 copies/PCR reaction for all targets

Available packages:

• IDRESPI-P1-100 (100 tests)
• IDRESPI-P1-500 (500 tests)

Solution for Direct PCR:

ID One-step LysMix 

• Ready-to-use mix for direct lysis within qPCR/PCR analysis from dry or liquid swabs
• Allows direct amplification of nucleic acids without an extraction step
• One additional step only to add 0.1 uL of the ID One-step LysMix into 8 uL of any PCR/qPCR mix

Available packages:

• IDOS-LYSMIX-500 (500 samples)